Cargando…
Comparing the Clinical Utility of Rapid Diagnostics for Treatment of Bloodstream Infections Using Desirability of Outcome Ranking Approach for the Management of Antibiotic Therapy (DOOR-MAT)
Decisions regarding which rapid diagnostic test (RDT) for bloodstream infections to implement remain challenging given the diversity of organisms detected by different platforms. We used the desirability of outcome ranking management of antimicrobial therapy (DOOR-MAT) as a framework to compare two...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370220/ https://www.ncbi.nlm.nih.gov/pubmed/34228533 http://dx.doi.org/10.1128/AAC.00441-21 |
_version_ | 1783739430255722496 |
---|---|
author | Claeys, Kimberly C. Hopkins, Teri L. Schlaffer, Kathryn Hitchcock, Stephanie Jiang, Yunyun Evans, Scott Johnson, J. Kristie Leekha, Surbhi |
author_facet | Claeys, Kimberly C. Hopkins, Teri L. Schlaffer, Kathryn Hitchcock, Stephanie Jiang, Yunyun Evans, Scott Johnson, J. Kristie Leekha, Surbhi |
author_sort | Claeys, Kimberly C. |
collection | PubMed |
description | Decisions regarding which rapid diagnostic test (RDT) for bloodstream infections to implement remain challenging given the diversity of organisms detected by different platforms. We used the desirability of outcome ranking management of antimicrobial therapy (DOOR-MAT) as a framework to compare two RDT platforms on potential desirability of antimicrobial therapy decisions. An observational study was performed at University of Maryland Medical System comparing Verigene blood culture (BC) to GenMark Dx ePlex blood culture ID (BCID) (research use only) panels on blood cultures from adult patients. Positive percent agreement (PPA) between each RDT platform and Vitek MS was calculated for comparison of on-panel targets. Theoretical antimicrobial decisions were made based on RDT results, taking into consideration patient parameters, antimicrobial stewardship practices, and local infectious diseases epidemiology. DOOR-MAT with a partial credit scoring system was applied to these decisions, and mean scores were compared across platforms using a paired t test. The study consisted of 160 unique patients. The Verigene BC PPA was 98.6% (95% confidence interval [CI], 95.1 to 99.8), and ePlex BCID PPA was 98% (95% CI, 94.3 to 99.6). Among the 31 organisms not on the Verigene BC panels, 61% were identified by the ePlex BCID panels. The mean (standard deviation [SD]) DOOR-MAT score for Verigene BC was 86.8 (28.5), while that for ePlex BCID was 91.9 (23.1) (P = 0.01). Both RDT platforms had high PPA for on-panel targets. The ePlex BCID was able to identify more organisms than Verigene, resulting in higher mean DOOR-MAT scores. |
format | Online Article Text |
id | pubmed-8370220 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-83702202022-02-17 Comparing the Clinical Utility of Rapid Diagnostics for Treatment of Bloodstream Infections Using Desirability of Outcome Ranking Approach for the Management of Antibiotic Therapy (DOOR-MAT) Claeys, Kimberly C. Hopkins, Teri L. Schlaffer, Kathryn Hitchcock, Stephanie Jiang, Yunyun Evans, Scott Johnson, J. Kristie Leekha, Surbhi Antimicrob Agents Chemother Clinical Therapeutics Decisions regarding which rapid diagnostic test (RDT) for bloodstream infections to implement remain challenging given the diversity of organisms detected by different platforms. We used the desirability of outcome ranking management of antimicrobial therapy (DOOR-MAT) as a framework to compare two RDT platforms on potential desirability of antimicrobial therapy decisions. An observational study was performed at University of Maryland Medical System comparing Verigene blood culture (BC) to GenMark Dx ePlex blood culture ID (BCID) (research use only) panels on blood cultures from adult patients. Positive percent agreement (PPA) between each RDT platform and Vitek MS was calculated for comparison of on-panel targets. Theoretical antimicrobial decisions were made based on RDT results, taking into consideration patient parameters, antimicrobial stewardship practices, and local infectious diseases epidemiology. DOOR-MAT with a partial credit scoring system was applied to these decisions, and mean scores were compared across platforms using a paired t test. The study consisted of 160 unique patients. The Verigene BC PPA was 98.6% (95% confidence interval [CI], 95.1 to 99.8), and ePlex BCID PPA was 98% (95% CI, 94.3 to 99.6). Among the 31 organisms not on the Verigene BC panels, 61% were identified by the ePlex BCID panels. The mean (standard deviation [SD]) DOOR-MAT score for Verigene BC was 86.8 (28.5), while that for ePlex BCID was 91.9 (23.1) (P = 0.01). Both RDT platforms had high PPA for on-panel targets. The ePlex BCID was able to identify more organisms than Verigene, resulting in higher mean DOOR-MAT scores. American Society for Microbiology 2021-08-17 /pmc/articles/PMC8370220/ /pubmed/34228533 http://dx.doi.org/10.1128/AAC.00441-21 Text en Copyright © 2021 Claeys et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Clinical Therapeutics Claeys, Kimberly C. Hopkins, Teri L. Schlaffer, Kathryn Hitchcock, Stephanie Jiang, Yunyun Evans, Scott Johnson, J. Kristie Leekha, Surbhi Comparing the Clinical Utility of Rapid Diagnostics for Treatment of Bloodstream Infections Using Desirability of Outcome Ranking Approach for the Management of Antibiotic Therapy (DOOR-MAT) |
title | Comparing the Clinical Utility of Rapid Diagnostics for Treatment of Bloodstream Infections Using Desirability of Outcome Ranking Approach for the Management of Antibiotic Therapy (DOOR-MAT) |
title_full | Comparing the Clinical Utility of Rapid Diagnostics for Treatment of Bloodstream Infections Using Desirability of Outcome Ranking Approach for the Management of Antibiotic Therapy (DOOR-MAT) |
title_fullStr | Comparing the Clinical Utility of Rapid Diagnostics for Treatment of Bloodstream Infections Using Desirability of Outcome Ranking Approach for the Management of Antibiotic Therapy (DOOR-MAT) |
title_full_unstemmed | Comparing the Clinical Utility of Rapid Diagnostics for Treatment of Bloodstream Infections Using Desirability of Outcome Ranking Approach for the Management of Antibiotic Therapy (DOOR-MAT) |
title_short | Comparing the Clinical Utility of Rapid Diagnostics for Treatment of Bloodstream Infections Using Desirability of Outcome Ranking Approach for the Management of Antibiotic Therapy (DOOR-MAT) |
title_sort | comparing the clinical utility of rapid diagnostics for treatment of bloodstream infections using desirability of outcome ranking approach for the management of antibiotic therapy (door-mat) |
topic | Clinical Therapeutics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370220/ https://www.ncbi.nlm.nih.gov/pubmed/34228533 http://dx.doi.org/10.1128/AAC.00441-21 |
work_keys_str_mv | AT claeyskimberlyc comparingtheclinicalutilityofrapiddiagnosticsfortreatmentofbloodstreaminfectionsusingdesirabilityofoutcomerankingapproachforthemanagementofantibiotictherapydoormat AT hopkinsteril comparingtheclinicalutilityofrapiddiagnosticsfortreatmentofbloodstreaminfectionsusingdesirabilityofoutcomerankingapproachforthemanagementofantibiotictherapydoormat AT schlafferkathryn comparingtheclinicalutilityofrapiddiagnosticsfortreatmentofbloodstreaminfectionsusingdesirabilityofoutcomerankingapproachforthemanagementofantibiotictherapydoormat AT hitchcockstephanie comparingtheclinicalutilityofrapiddiagnosticsfortreatmentofbloodstreaminfectionsusingdesirabilityofoutcomerankingapproachforthemanagementofantibiotictherapydoormat AT jiangyunyun comparingtheclinicalutilityofrapiddiagnosticsfortreatmentofbloodstreaminfectionsusingdesirabilityofoutcomerankingapproachforthemanagementofantibiotictherapydoormat AT evansscott comparingtheclinicalutilityofrapiddiagnosticsfortreatmentofbloodstreaminfectionsusingdesirabilityofoutcomerankingapproachforthemanagementofantibiotictherapydoormat AT johnsonjkristie comparingtheclinicalutilityofrapiddiagnosticsfortreatmentofbloodstreaminfectionsusingdesirabilityofoutcomerankingapproachforthemanagementofantibiotictherapydoormat AT leekhasurbhi comparingtheclinicalutilityofrapiddiagnosticsfortreatmentofbloodstreaminfectionsusingdesirabilityofoutcomerankingapproachforthemanagementofantibiotictherapydoormat |